The cardiovascular benefits of anti-obesity medications: a game-changer in heart health

Dr. Imran Aslam, Dr. Muhammad Kalim Raza, Dr. Ayesha Ashraf, Dr. Vishal Chauhan, Др. Имран Аслам, Др. Мухаммад Калим Раза, Др. Айеша Ашраф, Др. Вишал Чаухан, Dr. Imran Aslam, Dr. Muhammad Kalim Raza, Dr. Ayesha Ashraf, Dr. Vishal Chauhan

Research Focus · 2025-yil

Annotatsiya

Obesity is a significant global health challenge that increases the chance of developing cardiovascular disorders (CVDs), including heart failure, coronary artery disease, and hypertension. Traditional weight-loss methods often yield limited success, prompting the need for pharmacological interventions. Anti-obesity medications (AOMs) have emerged as effective tools for not only weight reduction but also improving cardiovascular health. This article explores the cardiovascular benefits of AOMs, including their role in lowering blood pressure, improving lipid profiles, reducing inflammation, and enhancing insulin sensitivity. Clinical trials, such as the SELECT and LEADER studies, provide strong evidence that medications like semaglutide, liraglutide, and tirzepatide significantly reduce major cardiovascular events. While AOMs offer promising heart health benefits, they should be integrated into a comprehensive lifestyle approach. This review highlights the transformative impact of anti-obesity medications in reducing cardiovascular risks and improving overall well-being.

Maqola ma’lumotlari
MualliflarDr. Imran Aslam, Dr. Muhammad Kalim Raza, Dr. Ayesha Ashraf, Dr. Vishal Chauhan, Др. Имран Аслам, Др. Мухаммад Калим Раза, Др. Айеша Ашраф, Др. Вишал Чаухан, Dr. Imran Aslam, Dr. Muhammad Kalim Raza, Dr. Ayesha Ashraf, Dr. Vishal Chauhan
JurnalResearch Focus
NashriyotВетеринария ИТИ ва “Илм-фан ва инновациялар академияси” МЧЖ
ISSN2181-3833
Nashr sanasi2025-04-05
Jild4
Son3
Betlar149-154
TilIngliz
Ilmiy sohaVeterinariya
DOI10.66073/researchfocus.v4i3.1524
Indeksga qo‘shilgan2026-09-08

Kalit so‘zlar

препараты против ожирения, здоровье сердечно-сосудистой системы, ожирение, потеря веса, гипертония, липидный профиль, чувствительность к инсулину, агонисты рецепторов GLP-1, профилактика сердечно-сосудистых заболеваний, метаболическое здоровье, Anti-obesity medications, cardiovascular health, obesity, weight loss, hypertension, lipid profile, insulin sensitivity, GLP-1 receptor agonists, cardiovascular disease prevention, metabolic health, Semizlikka qarshi dorilar, yurak-qon tomir salomatligi, semizlik, vazn yo'qotish, gipertoniya, lipid profili, insulinga sezgirlik, GLP-1 retseptorlari agonistlari, yurak-qon tomir kasalliklari profilaktikasi, metabolik salomatlik

Ilmiy soha

Iqtibos keltirish

APADr. Imran Aslam, Dr. Muhammad Kalim Raza, Dr. Ayesha Ashraf, Dr. Vishal Chauhan, Др. Имран Аслам, Др. Мухаммад Калим Раза, Др. Айеша Ашраф, Др. Вишал Чаухан, Dr. Imran Aslam, Dr. Muhammad Kalim Raza, Dr. Ayesha Ashraf, & Dr. Vishal Chauhan (2025). THE CARDIOVASCULAR BENEFITS OF ANTI-OBESITY MEDICATIONS: A GAME-CHANGER IN HEART HEALTH. Research Focus, 4(3), 149-154. https://doi.org/10.66073/researchfocus.v4i3.1524
GOST (OAK)Dr. Imran Aslam va b. THE CARDIOVASCULAR BENEFITS OF ANTI-OBESITY MEDICATIONS: A GAME-CHANGER IN HEART HEALTH // Research Focus. – 2025. – T. 4, № 3. – P. 149-154. – DOI: 10.66073/researchfocus.v4i3.1524.
MLADr. Imran Aslam, Dr. Muhammad Kalim Raza, Dr. Ayesha Ashraf, Dr. Vishal Chauhan, Др. Имран Аслам, Др. Мухаммад Калим Раза, Др. Айеша Ашраф, Др. Вишал Чаухан, Dr. Imran Aslam, Dr. Muhammad Kalim Raza, Dr. Ayesha Ashraf, and Dr. Vishal Chauhan. “THE CARDIOVASCULAR BENEFITS OF ANTI-OBESITY MEDICATIONS: A GAME-CHANGER IN HEART HEALTH.” Research Focus, 4(3), 149-154, 2025. https://doi.org/10.66073/researchfocus.v4i3.1524
ChicagoDr. Imran Aslam, Dr. Muhammad Kalim Raza, Dr. Ayesha Ashraf, Dr. Vishal Chauhan, Др. Имран Аслам, Др. Мухаммад Калим Раза, Др. Айеша Ашраф, Др. Вишал Чаухан, Dr. Imran Aslam, Dr. Muhammad Kalim Raza, Dr. Ayesha Ashraf, and Dr. Vishal Chauhan. “THE CARDIOVASCULAR BENEFITS OF ANTI-OBESITY MEDICATIONS: A GAME-CHANGER IN HEART HEALTH.” Research Focus, 4(3), 149-154 (2025). https://doi.org/10.66073/researchfocus.v4i3.1524
HarvardDr. Imran Aslam, Dr. Muhammad Kalim Raza, Dr. Ayesha Ashraf, Dr. Vishal Chauhan, Др. Имран Аслам, Др. Мухаммад Калим Раза, Др. Айеша Ашраф, Др. Вишал Чаухан, Dr. Imran Aslam, Dr. Muhammad Kalim Raza, Dr. Ayesha Ashraf, and Dr. Vishal Chauhan (2025) ‘THE CARDIOVASCULAR BENEFITS OF ANTI-OBESITY MEDICATIONS: A GAME-CHANGER IN HEART HEALTH’, Research Focus, 4(3), 149-154. https://doi.org/10.66073/researchfocus.v4i3.1524
BibTeX
@article{drimranaslam2025,
  title = {THE CARDIOVASCULAR BENEFITS OF ANTI-OBESITY MEDICATIONS: A GAME-CHANGER IN HEART HEALTH},
  author = {Dr. Imran Aslam and Dr. Muhammad Kalim Raza and Dr. Ayesha Ashraf and Dr. Vishal Chauhan and Др. Имран Аслам and Др. Мухаммад Калим Раза and Др. Айеша Ашраф and Др. Вишал Чаухан and Dr. Imran Aslam and Dr. Muhammad Kalim Raza and Dr. Ayesha Ashraf and Dr. Vishal Chauhan},
  journal = {Research Focus},
  year = {2025},
  volume = {4},
  number = {3},
  pages = {149-154},
  doi = {10.66073/researchfocus.v4i3.1524},
  url = {https://doi.org/10.66073/researchfocus.v4i3.1524}
}

Boshqa maqola uchun iqtibos tayyorlash

Research Focus jurnalidan boshqa maqolalar

Research Focus — barcha maqolalar · 2025-yil arxivi

Veterinariya sohasidagi boshqa maqolalar

Veterinariya sohasidagi OAK jurnallari